(Q83438797)
Statements
The pharmacological advantage of prolonged dose rate gemcitabine is restricted to patients with variant alleles of cytidine deaminase c.79A>C (English)
Ekkaphon Metharom
Susan Manners
Maria Jelinek
Winston Liauw
Paul L de Souza
Janelle M Hoskins
30 December 2010